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The γ-secretase complex, composed of four non-covalently bound transmembrane proteins Presenilin, Nicastrin (NCT), APH-1 and PEN-2, is
responsible for the intramembranous cleavage of amyloid precursor protein (APP), Notch and several other type I transmembrane proteins. γ-
Secretase cleavage of APP releases the Aβ peptides, which form the amyloid plaques characteristic of Alzheimer's disease brains, and cleavage of
Notch releases an intracellular signalling peptide that is critical for numerous developmental processes. NCT, a type I membrane protein, is the
only protein within the complex that is glycosylated. The importance of these glycosylation sites is not fully understood. Here, we have observed
that NCT N-linked oligosaccharides mediated specific interactions with the secretory pathway lectins calnexin and ERGIC-53. In order to
investigate the role played by N-glycosylation, mutation of each site was performed. All hNCT mutants interacted with calnexin and ERGIC-53,
indicating that the association was not mediated by any single N-glycosylation site. Moreover, the interaction with ERGIC-53 still occurred in
PS1/2 double knockout cells as detected in immunoprecipitation as well as confocal immunofluorescence microscopy studies, which indicated that
NCT interacted with ERGIC-53 prior to its association with the active γ-secretase complex.
© 2006 Elsevier B.V. All rights reserved.Keywords: Alzheimer's disease; Nicastrin; γ-secretase complex; N-glycosylation; Calnexin; ERGIC-531. Introduction
Alzheimer's disease (AD) is a neurodegenerative disorder
that is characterized by two pathological hallmarks: the
accumulation of senile plaques composed predominantly of
amyloid-β (Aβ) peptide and of neurofibrillary tangles
(reviewed in [1]). The Aβ peptide arises from the sequential
cleavage of the amyloid precursor protein (APP), a type I
transmembrane protein [2]. Two distinct enzymatic activities
cleave APP giving rise to the Aβ peptide. First, the β-site
APP cleaving enzyme (BACE) cleaves APP, generating a C-
terminal 99-amino acid long membrane anchored fragment
termed C99. Subsequently, cleavage of C99 within its
transmembrane domain (TMD) by the γ-secretase complex⁎ Corresponding author. Tel.: +351 21 4469437; fax: +351 21 4411277.
E-mail address: jcosta@itqb.unl.pt (J. Costa).
0925-4439/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2006.06.018generates different species of Aβ peptide that differ slightly in
length but vary greatly in their ability to aggregate, and an
intracellular APP C-terminal domain [3,4]. In addition to APP,
several other membrane proteins undergo regulated cleavage
by γ-secretase, such as Notch, a cell surface receptor that is
required for various cell fate decisions during embryogenesis
[5].
The γ-secretase complex is a unique aspartyl protease whose
active site appears to reside within the membrane. At present,
the γ-secretase complex is composed by four noncovalently
associated proteins: presenilin-1 (PS1) or its less abundant form
presenilin-2 (PS2) [6], nicastrin (NCT) [7–10], PEN-2 and
APH-1 [11,12]. Presenilin is believed to be the catalytic
component of the complex [13–15], whereas NCT, PEN-2 and
APH-1 were discovered more recently. NCT, a type I transmem-
brane protein, was isolated by biochemical co-purification with
PS [10] and associates with the other γ-secretase components
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component of the γ-secretase complex that is glycosylated,
though the roles played by the 16 potential N-linked
oligosaccharides in NCT structure and function are not clear.
Recently, it has been proposed that oligosaccharides may be
involved in the initiation of the correct folding of some
polypeptides in the ER [19]. Furthermore, proper folding of
glycoproteins is facilitated in the ER by a battery of classical
molecular chaperones (BiP, calnexin (CNX), calreticulin), and
by proteins that catalyse protein disulfide-bond formation (PDI,
Erp57). Altogether, they form a mechanism globally referred
to as the “quality control” of protein folding [20]. Therefore,
N-linked oligosaccharides do not only play a role in protein
folding, but also have an active part in the quality control
system [21].
Additionally, transport to subcellular compartments some-
times requires specialized pathways. After passing the CNX
and calreticulin quality control cycle of the ER, glycoprotein
transport from this compartment to the Golgi occurs, which
involves the budding of COP-II coated vesicles from the ER
that fuse with the ER-Golgi-Intermediate-Compartment
(ERGIC), a subcellular structure that is composed of a
multitude of tubulovesicular clusters in the vicinity of the
cis-Golgi [22]. The lectin ERGIC-53, an unglycosylated type I
transmembrane protein that cycles between the ER and the
ERGIC [22,23], has properties of a mannose-selective lectin in
vivo [24]. Lack of ERGIC-53 expression impairs secretion of
a set of soluble glycoproteins, including blood coagulation
factors V and VIII [25], and the cathepsin C precursor [26]. It
has been suggested that the functional role of ERGIC-53 may
be to operate as a molecular receptor for a specific subset of
soluble, mannose-containing glycoproteins promoting their
concentration in COPII vesicles followed by transport from
the ER to the ERGIC.
In this study we have investigated the importance of the
N-linked oligosaccharides present on human NCT (hNCT)
for γ-secretase trafficking and activity. NCT specifically
interacted with the lectins CNX and ERGIC-53. The
interaction with ERGIC-53 was independent of PS1 associa-
tion, and was not specific for any single N-glycosylation
site. To the best of our knowledge, this is the first time that
ERGIC-53 has been shown to associate with a membrane
glycoprotein.
2. Materials and methods
2.1. DNA constructs
Expression vectors encoding for hNCT with a V5 epitope tag at the C-
terminus (hNCT-V5) [18], human PS1 [27], APH-1a-HA and PEN-2-HA [28]
have been previously described. Briefly, the cDNA encoding hNCT was a kind
gift from Dr. Sangram Sisodia (University of Chicago, IL, USA) and was cloned
into pcDNA3.1D/V5-His TOPO plasmid (Invitrogen) with the V5 tag epitope at
the C-terminus of the protein. APH-1a and PEN-2 were cloned from a liver
cDNA library (Clontech) and the resulting PCR products were cloned into
pcDNA3.1D/V5-His TOPO plasmid (Invitrogen). The 3′ HA epitope tag was
introduced in-frame by PCR.
Single N-glycosylation sites mutants of hNCT (hNCTΔ) were obtained
by site-directed mutagenesis using QuickChange cloning techniques asdescribed by the manufacturer (Stratagene). Briefly, potential N-glycosylation
sites with the known consensus sequence NXS/T were mutated to NXA. All
hNCT and hNCTΔ constructs had a V5-tag epitope at the C-terminus of each
protein for detection purposes. The identity of all plasmids and corresponding
mutations were confirmed by sequencing analysis.
The plasmid encoding ERGIC-53 with a myc epitope tag introduced after
the signal sequence (ERGIC-53-myc) [24] was a kind gift from Prof. H. P. Hauri
(Biozentrum, University of Basel, Switzerland).
2.2. Cell culture and protein expression
NCT-deficient mouse embryonic fibroblasts (NCT−/−) and PS-1 and PS-2
deficient mouse embryonic stem cells (PS−/−) cells have been previously
described [29,30]. Human embryonic kidney (HEK) 293T and NCT−/− cells
were cultured in Dulbecco's modified Eagle's medium (DMEM) with high
glucose concentration (Gibco) supplemented with 10% fetal bovine serum
(FBS) (Hyclone) and 1% penicillin/streptomycin. ES cells, either wild-type
(PS+/+) or deficient for PS1/2 (PS−/−), were grown in DMEM supplemented
with 15% FBS, non-essential amino acids, 2 mM L-glutamine, 1 mM sodium
pyruvate, 100 μM β-mercaptoethanol, 1% penicillin/streptomycin and 105
Units/l murine leukemia inhibitory factor (Chemicon). For transient expres-
sion, all cells were transfected with 2 μg total DNA at approximately 70%
confluency in 10 cm2 dishes (approximately 1×106 cell/dish) with Lipo-
fectamine2000 (Invitrogen) according to the supplier's protocol. For hNCT
expression in HEK293T cells, quadruple transfections with plasmids encoding
for hPS1, hAPH-1-HA, hPEN-2-HA (0.5 μg of each plasmid) were performed,
and for the cases where ERGIC-53-myc was also expressed 0.4 μg of each
plasmid were used. For expression in NCT−/− MEF cells and PS−/− or PS+/+
ES cells, double transfections with plasmids encoding for hNCT and ERGIC-
53 (1 μg of each plasmid) were performed. The plasmid encoding for green
fluorescent protein (pTARGET-GFP), a non-related protein, was used to
equalize the total amount of DNA transfected.
2.3. Antibodies
For immunoprecipitation studies the following antibodies were used: 7 μl
rabbit polyclonal #1712, which was produced by immunization of rabbits with
purified recombinant thioredoxin-V5/His [31] for V5 tagged proteins, 5 μl
mouse monoclonal anti-myc tag (clone 9E10) for myc tagged proteins, 10 μl
goat polyclonal anti-CNX-C20 raised against the C-terminus of human CNX
(Santa Cruz Biotechnologies), and 3 μl mouse monoclonal anti-PS1-NTF
antibody raised against the NTF region of PS1 (antibody14); this antibody
was a kind gift from Prof. Sam Gandy (Thomas Jefferson University, PA,
USA).
For Western blot analysis, a mouse monoclonal anti-V5 epitope tag antibody
(Invitrogen) was used for V5 epitope tagged protein visualization, and a
polyclonal rabbit anti-NCT (Cell Signalling Technology) was used for
endogenous NCT visualization.
2.4. Western blot analysis
For protein analysis, 24 h post-transfection, cell extracts were prepared in
50 mM Tris–HCl pH 7.4, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100 and
protease inhibitor cocktail (Roche). Cell lysates were incubated at 4 °C for
30 min, centrifuged at 10,000×g for 10 min, and analyzed by SDS-PAGE with
10% acrylamide followed byWestern blot analysis using horseradish peroxidase
(HRP)-conjugated secondary antibody. Visualization was performed with ECL-
Plus Western Blotting Detection Reagents (Amersham).
2.5. Co-immunoprecipitation
Co-immunoprecipitation assays were performed as previously described
[28]. Briefly, cells (1×106 cells) were lysed with 0.5 ml lysis buffer containing
50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1% 3-[(3-cholamidopropyl)
dimethylammonio]-2-hydroxyl-1-propanesulfonate (CHAPSO), 5 mM EDTA
and protease inhibitor cocktail. Pre-cleared lysates were incubated for 1 h at 4 °C
with antibody previously coupled to protein A/G Plus agarose beads (Santa Cruz
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with 20 μl sample buffer (0.08 M Tris–HCl pH 6.8, 2% sodium dodecylsulfate,
10% glycerol, 5% β-mercaptoethanol, 0.005% bromophenol blue). Samples
were analyzed by Western blot as described above.
2.6. Glycosidase hydrolysis
Cell lysates were incubated with peptide: N-glycosidase F (PNGaseF) and
endoglycosidase H (EndoH) according to supplier's protocol (New England
Biolabs). Briefly, 30 μl of cell lysate (approximately 1.2×105 cell) were
denatured in glycoprotein denaturing buffer at 100 °C for 10 min, and incubated
with deglycosylation enzyme (PNGaseF or EndoH) in the corresponding buffer.
Hydrolysis was carried out at 37 °C for 3 h. The samples were further analyzed
by Western blot with anti-V5 antibody as described above.
2.7. Immunofluorescence microscopy
Murine PS+/+ and PS−/− were grown on glass coverslips to half-confluence,
and transfected with hNCT-V5 and ERGIC-53-myc. Twenty-four hours post-
transfection, cells were washed with PBS containing 0.5 mM MgCl2, fixed
with 4% (w/v) paraformaldehyde in PBS for 20 min and permeabilized with
0.1% (w/v) TX-100 in PBS for 15 min. Blocking was done with 1% BSA in
PBS for 1 h and the coverslips incubated at room temperature for 2 and 1 h
with primary and secondary antibodies, respectively. Antibody solutions were
prepared in PBS containing 1% (w/v) BSA and washing was performed with
PBS. Primary antibodies were rabbit anti-V5 epitope tag (1/500) [31], mouse
anti-GM130 (1/200) (BD Bioscience) and mouse anti-myc (1/100); and
secondary antibodies were donkey anti-mouse AlexaFluor-488 and donkey
anti-rabbit AlexaFluor-594 (1/500) (Molecular Probes). Coverslips were
mounted in Airvol and examined on a Leica Confocal (SP2+AOBS)
microscope. For each picture, laser intensities and amplifier gains were
adjusted in order to avoid pixel saturation. This was done using the GLOW
LUT on the Leica Confocal Software. Each fluorofore used was excited and
sequential detection was performed. Each picture consisted of a z-series of 20
images of 1024×1024 pixel resolution with a pinhole of 1.0 Airy unit.
Colocalization analysis was performed using the open source Image J software
version 1.30 (http://www.rsb.info.nih.gov/ij/).Fig. 1. hNCT associates with CNX. HEK293T cells transfected with hNCT-V5
(indicated above the figure) were lysed in 1% TX-100 lysis buffer and co-
immunoprecipitated with a goat polyclonal anti-CNX antibody (IP: anti-CNX).
Co-immunoprecipitation was performed with approximately 1×106 cells. The
NCT form co-immunoprecipitated with CNX was treated with EndoH (third
lane). As controls direct analysis of the cell lysate (approximately 2×104 cells)
(first lane), co-immunoprecipitation where cell lysate was replaced by lysis
buffer (fourth lane), and co-immunoprecipitation in the absence of antibody
(fifth lane) were performed. Western blot was probed with mouse monoclonal
anti-V5 tag antibody for hNCT detection. Mature NCT (mNCT), immature
NCT (imNCT) and monoglucosylated NCT (mgNCT) are indicated in the
figure.3. Results
3.1. hNCT associates with the lectins calnexin and ERGIC-53
For many glycoproteins, N-linked oligosaccharides play an
active role in folding via association with CNX and calreticulin,
chaperones that interact with newly synthesized glycoproteins
in the ER [32,33]. We observed that hNCTwt associated with
CNX through co-immunoprecipitation of CNX in HEK293T
cells expressing hNCTwt followed by Western blot analysis
(Fig. 1). Interestingly, comparison between the expression input
levels and the co-immunoprecipitation data showed that the
form of hNCT that associated with CNX (mgNCT in Fig. 1,
second lane) in the Western blot analysis appeared at a
molecular mass (MM) that was intermediate between the
mature and immature forms of hNCT (mNCT and imNCT,
respectively, in Fig. 1, first lane). The mgNCT form was
sensitive to hydrolysis with EndoH (Fig. 1, third lane), and the
product presented an apparent MM of approximately 80 kDa
after hydrolysis. The hydrolysis results confirmed that mgNCT
contained high-mannose type structures. This form of NCT
probably corresponded to the monoglucosylated form, which
has been reported in the case of other glycoproteins to have
affinity for CNX [34].In addition to CNX, other chaperones may also interact with
newly synthesized glycoproteins. To investigate if ERGIC-53, a
cargo receptor that mediates transport between the ER and
ERGIC compartment through association with mannose
residues present on glycoproteins, was capable of interacting
with NCT, co-immunoprecipitation assays with HEK293T cells
expressing a tagged version of ERGIC-53 (ERGIC-53-myc)
and hNCTwt tagged with the V5 epitope (hNCT-V5) were
performed. The results indicated that the immature form of
hNCT associated with ERGIC-53 (Fig. 2A, third lane). Using
higher exposure periods, we also observed that the mature form
of hNCT was not co-immunoprecipitated with ERGIC-53 (data
not shown).
In order to verify that the association between ERGIC-53 and
hNCT was specific, a competition assay for the carbohydrate-
binding site present on ERGIC-53 was also performed with
methyl-α-D-mannopyranoside (αMM) (Fig. 2A, fourth lane).
As expected, no hNCT binding was detected in the presence of
αMM, indicating that this monosaccharide competed with the
mannose containing oligosaccharides present on hNCT. More-
over, the same procedure performed in the presence of D- (+)-
glucose showed that ERGIC-53 still interacted with hNCT (Fig.
2A, sixth lane), indicating that the disruption of the established
association was mannose dependent. As control, we have
observed that the presence of αMM did not disrupt γ-secretase
complex association since hNCT could still be co-immunopre-
cipitated with hPS1 (Fig. 2B). Furthermore, there was no
unspecific binding of hNCT to the protein A/G-agarose beads in
the absence of anti-V5 antibody (Fig. 2C). Finally, the
incubation with αMM did not inhibit immunoprecipitation
using anti-V5 antibody (Fig. 2D). Together these results further
supported that the interaction of ERGIC-53 with hNCT was
specific.
Fig. 2. hNCTassociates with ERGIC-53. HEK293Tcells, transfected with ERGIC-53-myc and hNCT-V5 (indicated above the Figure) were lysed in 1% CHAPSO and
co-immunoprecipitated with a mouse monoclonal anti-myc antibody for ERGIC-53 (A), with a mouse monoclonal anti-PS1 antibody (B), and with a rabbit polyclonal
anti-V5 antibody for hNCT-V5 (D). A competition assay was performed where 0.3 M methyl-α-D-mannopyranoside (αMM), H20, or 0.3 M D-(+)-glucose (Glc) was
added to the cell lysate before immunoprecipitation. Immunoprecipitates and corresponding cell lysates (Input) were analyzed by Western blot with a mouse
monoclonal anti-V5 tag antibody to detect hNCT. An immunoprecipitation assay was performed in the absence of antibody (C, no Ab) to verify that co-
immunoprecipitation results were not due to interaction of hNCT-V5 with protein-A/G agarose beads.
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To further characterize the role that N-glycosylation of NCT
may play in mediating this interaction with CNX and ERGIC-
53, site-directed mutagenesis was performed to mutate
individual N-glycosylation sites in hNCT. Briefly, each mutant
construct was obtained using the QuickChange cloning
technique, where the potential N-glycosylation site was changed
from NXS/T to NXA. The mutants are referred to as hNCTΔ
followed by the amino acid number of the altered residue.
To assess whether the hNCTΔ constructs were transported
properly, their glycosylation pattern was analysed after enzy-
matic deglycosylation with PNGaseF and EndoH. As expected,hNCTwt appeared as both immature (imNCT, approximately
110 kDa) and mature (mNCT, approximately 130 kDa) form
(Fig. 3). After hydrolysis with PNGaseF, which cleaves between
the innermost GlcNAc and Asn residues of high mannose,
hybrid and complex N-linked oligosaccharides, hNCTwt
appeared with an apparent MM of approximately 80 kDa (Fig.
3) which corresponded to a totally deglycosylated form. In the
presence of EndoH, which cleaves between the core GlcNAc-
GlcNAc residues of high mannose and some hybrid N-linked
oligosaccharides, hNCTwt appeared as two bands, one of which
co-migrated with fully deglycosylated NCT representing protein
in the ER and early Golgi (Fig. 3) . The second band was
partially resistant to EndoH at approximately 110kDa (Fig. 3) ,
Fig. 3. Enzymatic deglycosylation of hNCT N-glycosylation mutants. HEK293Tcells were transfected with hNCTor one of the fifteen hNCTΔmutants, all containing
a C-terminal V5 epitope tag for detection purposes. Cells were lysed in buffer containing 1% TX-100 and hydrolyzed with PNGaseF, EndoH or lysis buffer as a
control. Western blot analysis using anti-V5 antibody was performed. The immature (imNCT) and mature (mNCT) forms of NCT can be visualized, as well as the
EndoH resistant Golgi processed and the deglycosylated forms of hNCT.
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N-linked oligosaccharides have been processed in the Golgi to
complex forms. The hNCTΔ mutants as well as NCTwt
presented an immature EndoH sensitive ER form and a mature
EndoH resistant Golgi form (Fig. 3). The mutation of a single
N-glycosylation site did not allow us to verify if any of the
mature hNCTΔ mutants were exhibiting a different EndoH
resistance pattern. However, performing combined mutations
of N-glycosylation sites could clarify this aspect. This
experiment revealed that none of the single N-glycosylation
site mutations disrupted transport and maturation of hNCT.
Previous studies have shown that an active γ-secretase
complex requires the presence of a functional NCT for the
endoproteolysis of PS1 [30] and processing of Notch [5] to
occur. In order to determine if cleavage of PS1 and NotchΔE, a
truncated form of Notch [35], was occurring in the presence of
hNCTΔ mutants, NCT−/− cells were transfected with the
indicated hNCTΔ mutants and with hPS1 or NotchΔE, respect-
ively. Western blot analysis of cell lysates showed that hNCTwt
and the hNCTΔ mutants were capable of mediating endopro-Fig. 4. Association of CNX with N-glycosylation mutants of NCT. HEK293T cells, en
lysed in buffer containing 1% CHAPSO and co-immunoprecipitated with an antibody
antibody to detect co-immunoprecipitated hNCT and deletion mutants (A). Correspon
by Western blot against anti-V5 antibody (B). Both immature (imNCT), monoglucos
figure.teolysis of hPS1 and of cleaving NotchΔE (data not shown),
indicating that no single N-glycosylation site deletion was
sufficient to ablate γ-secretase activity. However, analysis of
PS1-NTF produced and the amount of cleaved Notch product in
the presence of each NCTΔ mutant showed an apparent
reduction in γ-secretase activity when compared to hNCTwt.
Further studies need to be performed in order to confirm this
apparent reduction observed in activity. Ideally, functional
assays should be performed in stable hNCTΔ mutant cell lines,
or with an in vitro functional assay where hNCTΔmutants were
incorporated in the reconstituted γ-secretase activity.
3.3. Association of hNCTΔ mutants with lectins CNX and
ERGIC-53
In order to understand which N-glycosylation site was
mediating the association with lectins CNX and ERGIC-53,
HEK293T cells expressing hNCTΔ constructs were co-
immunoprecipitated with CNX (Fig. 4A). As expected, when
taking into account the maturation pattern obtained for eachdogenously expressing calnexin (CNX) and the indicated hNCTΔmutants were
to CNX. The immunoprecipitates were analyzed byWestern blot with an anti-V5
ding cell lysates were analyzed for hNCT and hNCTΔ mutant expression levels
ylated NCT (mgNCT) and mature (mNCT) forms of NCTwere indicated in the
Fig. 5. Association of ERGIC-53 with N-glycosylation mutants of NCT. HEK293T cells, expressing ERGIC-53-myc and the indicated hNCTΔ mutants were lysed in
buffer containing 1% CHAPSO and co-immunoprecipitated with an antibody to myc-epitope tag. The immunoprecipitates were analyzed byWestern blot with an anti-
V5 antibody to detect co-immunoprecipitated hNCT and deletion mutants (A). Corresponding cell lysates were analyzed for hNCT and hNCTΔ mutant expression
levels byWestern blot against anti-V5 antibody (B). Both immature (imNCT) and mature (mNCT) forms of NCTwere indicated in the figure. Input-hNCT is a control-
loading lane to facilitate hNCT band pattern visualization.
Fig. 6. hNCT/ERGIC-53 association occurs in the absence of PS1/2. Murine
PS+/+ and PS−/− cells, (A) expressing hNCT-V5 and ERGIC-53-myc, were lysed
in buffer containing 1% CHAPSO and immunoprecipitated with an antibody to
myc-epitope tag present on ERGIC-53. Immunoprecipitates were analysed by
Western blot with anti-V5 tag antibody to detect hNCT. Western blot analysis of
endogenous NCT (B) was performed in cell lysates prepared in buffer
containing 1% TX-100 using a rabbit polyclonal anti-NCT antibody. Immature
form of NCT (imNCT) was indicated in the figure.
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interacting with CNX. This result indicated that all hNCTΔ
mutants acquired a proper fold via association with CNX.
Additionally, hNCTΔ constructs and ERGIC-53 co-immu-
noprecipitation assays were performed in HEK293T cells
expressing ERGIC-53-myc and hNCTΔ mutants. Despite the
absence of specific N-linked oligosaccharide sites on hNCT,
ERGIC-53 was capable of associating with each hNCTΔ
mutant (Fig. 5A), indicating that this association was not
mediated by any single N-glycosylation site. In all cases,
comparison with non-immunoprecipitated hNCT (Fig. 5A,
Input-hNCT) showed that only the immature forms of the
hNCTΔ mutants were detected to interact with ERGIC-53,
despite the presence of both immature and mature hNCT forms
in the corresponding cell lysates (Fig. 5B). These results could
be explained by the recognition specificity of ERGIC-53
towards high-mannose type oligosaccharides from N-glycosy-
lated proteins [39], and to the higher amounts of immature
hNCT relative to mature hNCT present in the extracts (Fig. 5B).
3.4. NCT / ERGIC-53 association occurs in the absence of PS1
To determine if the presence of PS is required for the
association between hNCT and the lectin ERGIC-53, co-
immunoprecipitation assays with murine PS+/+ and PS−/− cells
expressing ERGIC-53-myc and hNCT-V5 were performed (Fig.
6A). The results showed that hNCT associated with ERGIC-53
independently of the presence of PS. Detection of endogenous
NCT in PS+/+ and PS−/− cells, showed that the presence of PS
was required for the maturation of NCT and that probably only
in the presence of PS did trafficking of NCT to the Golgi occur
(Fig. 6B), as previously shown by other authors [29,36,37].
These findings were also verified by confocal microscopy
where co-localization between ERGIC-53 and hNCT was
observed in both murine PS+/+ and PS−/− cells expressing
ERGIC-53-myc and hNCT-V5 (Fig. 7). This indicated that the
presence of PS is not a prerequisite for association between
NCT and ERGIC-53 to occur. We further observed that ERGIC-
53 was found in vesicles throughout the cytoplasma in PS+/+
cells, however, it appeared in larger vesicles in the perinuclear
area for the PS−/− cells. Therefore, the absence of PS appears tointerfere with the dynamics and morphology of the ERGIC
compartment. In spite of this, co-localization of hNCT and
ERGIC-53 was still observed.
Additional co-localization studies between hNCT-V5 and
GM130, a cis-Golgi resident protein, were performed in both
cell lines. We observed that in PS+/+ cells the majority of hNCT
co-localized with GM130, which indicated that it was trans-
ported to the Golgi compartment. On the other hand, in PS−/−
cells co-localization with GM130 was very low, most of the
fluorescence spread throughout the cytoplasma (Fig. 7). These
results indicated that PS was required for hNCT trafficking to
the Golgi compartment to occur.
Therefore, the immature NCT form, present in the PS−/−
cells, was capable of associating with ERGIC-53. Furthermore,
Fig. 7. Confocal immunofluorescence microscopy analysis of hNCT in PS+/+ and PS−/− cells. Immunofluorescence microscopy was performed in murine PS+/+ and
PS−/− cells expressing hNCT-V5 and ERGIC-53-myc. Cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% TX-100 and processed for double
labelling. Primary antibodies were the following: rabbit anti-V5 (hNCT-V5, red), mouse anti-GM130 (green) and mouse anti-myc (ERGIC-53-myc, green). Secondary
antibodies were anti-rabbit coupled to Alexa 594 (red) and anti-mouse coupled to Alexa 488 (green). Merge panels show co-localization areas (yellow). Magnification:
630-fold, zoom 2. Scale bar: 10 μm.
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be transported to the Golgi.
4. Discussion
NCT is one of the four components identified as part of the
γ-secretase complex, an unusual membrane-bound aspartyl
protease with the ability to cleave certain substrate proteins at
peptide bonds buried within the hydrophobic environment of
the lipid bilayer. NCT, a type I transmembrane glycoproteinwith 16 potential N-glycosylation sites, has been shown to
contain a mixture of high-mannose and complex type
oligosaccharides. The importance of this extensive carbohy-
drate array for NCT function is not fully understood. To
investigate more carefully the role of NCT folding and how this
regulates its transport from the ER, we investigated the
interaction of hNCT with lectin-like molecular chaperones
from the quality control/secretory pathway: CNX [38] and
ERGIC-53 [22]. We observed that hNCTwt strongly interacted
with CNX, which indicated that this chaperone participated in
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probably uses this quality control pathway to acquire a proper
fold. Since the ectodomain of Nicastrin has been implicated in
the recognition of γ-secretase substrates [40], it is probable that
the interaction hNCT/CNX is important to promote a proper
conformation of hNCT ectodomain, which is essential for sub-
strate recognition.
N-linked oligosaccharides not only have a functional role in
protein folding, but in some cases, are also involved in
transport and targeting of glycoproteins. ERGIC-53, a lectin
transport receptor, recognizes folded, high-mannose type
glycoproteins in the ER [39] after they have been released
from the quality control machinery for glycoprotein folding
(calnexin/calreticulin) and subjected to glucose trimming [32].
In this study we have shown that ERGIC-53 specifically
interacted with hNCT, and that the presence of αMM disrupted
this association, indicating that this interaction was carbohy-
drate specific, and involved high-mannose type oligosacchar-
ides from hNCT and the carbohydrate recognition domain
(CRD) from ERGIC-53.
To determine if any specific N-linked glycosylation sites
were important for NCT interaction with CNX and ERGIC-53,
we produced single site deletion mutants (hNCTΔ) lacking each
of the N-linked addition sites in turn. Association of hNCTΔ
mutants with CNX and ERGIC-53 still occurred, indicating that
these mutants were acquiring a proper fold via the CNX quality
control pathway and that hNCT had more than one site
containing high mannose type oligosaccharides. Furthermore,
association between NCT/ERGIC-53 was not specific for a
single site. At this point, the benefit of the NCT/ERGIC-53
association is not fully understood. A likely scenario is that
ERGIC-53 may act as a transport chaperone facilitating ER to
ERGIC transport of the γ-secretase complex, or that to some
extent ERGIC-53 may stabilize the γ-secretase complex in the
ER and thereby promote optimal assembly of NCTwith other γ-
secretase complex components.
Another interesting feature about this complex is that the
presence of each γ-secretase component influences the target-
ing/maturation of the other components. In the present work we
have observed that the mature form of NCT is largely or
completely absent in murine PS−/− cells and that trafficking of
NCT to the Golgi does not occur in these cells , with only the
immature EndoH-sensitive NCT band being observed, as has
been reported by others [29,36,37]. Despite the absence of PS1/
2, NCTwas still capable of associating with ERGIC-53. An ER-
retention signal has been found to exist on the C-terminus of PS
that could prevent unassembled subunits from leaving the ER,
but that is masked upon full assembly [41]. It is also possible
that NCT could contain an ER-retention signal that would be
masked upon association with other members of the γ-secretase
complex. In such a model, one could postulate that NCTwould
interact with ERGIC-53 in the ER and that transport of the
γ-secretase complex via this cargo receptor lectin would occur
after association of NCT with PS. Further studies need to be
performed to understand in more detail the importance of the γ-
secretase complex requiring the cargo receptor lectin ERGIC-53
for transport/targeting to the ERGIC/cis-Golgi compartment.In summary, NCT interacts with secretory pathway lectins
CNX and ERGIC-53. N-glycosylation sites influence the proper
folding of NCT on one hand, and seem to have a role in ER-
assembly and ER-exit of NCT, on the other hand.
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